ATX
Amplia Therapeutics Ltd
Biotechnology
·
Healthcare
5
comments
4
fund managers
past 90 days
About Amplia Therapeutics Ltd
Amplia Therapeutics Ltd. is an Australian biotechnology company based in Melbourne. Founded in 2000, the firm specializes in developing drug candidates for oncology and chronic fibrosis. Its core platform utilizes immuno-modulator microparticles designed to activate the immune system against cancers and infections, while also modulating mechanisms related to autoimmune conditions like multiple sclerosis. The company remains focused on drug development across these therapeutic areas.
Commentary Volume
5
Comments
4
Fund managers
0
Past 90 days
SOURCE
ACTION
COMMENT PREVIEW
FUND MANAGER
DATE
Loading...
.
​Loading...
Loading...
Loading...
Loading...
Source: Ipsum Capital Q4 Quarterly Letter · Published 14 March 2025
Report a problem
Loading...
.
Loading...
Loading...
Loading...
Loading...
§ Important Notice
The entries below are records originating from third-party statements. Thesis Tracker does not rank, recommend or endorse any fund manager, fund or security. Investment decisions should be made on the basis of the relevant Product Disclosure Statement and, where appropriate, advice from a licensed adviser.
Commentary
Sector
Healthcare
Market cap
$67M
Fund managers
4 managers
First covered
31 Oct 2024
Last updated
31 Mar 2026
Company Details
Related Themes
ic
Ipsum Capital
6 comments
ic
Amet Funds
4 comments
ic
Dolor
3 comments
Top Investors Covering MIN
§ Reminder
The entries above are records originating from third-party statements. Thesis Tracker does not rank, recommend or endorse any fund manager, fund or security. Investment decisions should be made on the basis of the relevant Product Disclosure Statement and, where appropriate, advice from a licensed adviser.
Frequently asked questions about Amplia Therapeutics Ltd (ASX:ATX)
Frequently asked questions
Who is investing in Amplia Therapeutics Ltd (ASX:ATX)?
Fund managers including Pengana Capital Group, SG Hiscock & Company, Acorn Capital and Pengana Capital have invested in Amplia Therapeutics Ltd (ASX:ATX).
What is the short interest in Amplia Therapeutics Ltd (ASX:ATX)?
The short interest in Amplia Therapeutics Ltd (ASX:ATX) is 0.05% which makes it the 452nd most shorted stock on the ASX. Of the 513.1M shares that Amplia Therapeutics Ltd has on issue, 276.7K have been sold short.
What does Amplia Therapeutics Ltd (ASX:ATX) do?
Amplia Therapeutics Ltd. is an Australian biotechnology company based in Melbourne. Founded in 2000, the firm specializes in developing drug candidates for oncology and chronic fibrosis. Its core platform utilizes immuno-modulator microparticles designed to activate the immune system against cancers and infections, while also modulating mechanisms related to autoimmune conditions like multiple sclerosis. The company remains focused on drug development across these therapeutic areas.
Loading...